These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6645503)

  • 1. Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
    Witzgall H; von Werder K; Weber PC
    J Steroid Biochem; 1983 Nov; 19(5):1671-6. PubMed ID: 6645503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
    Shimizu Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
    Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
    Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
    Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
    Jungmann E; Althoff PH; Rosak C; Schwedes U; Schöffling K
    Horm Metab Res; 1986 Feb; 18(2):138-40. PubMed ID: 3699687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
    Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
    Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
    Ojima M; Itoh N; Kusano Y; Yaginuma K; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):197-207. PubMed ID: 3709883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
    Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
    Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.
    Rossitto G; Maiolino G; Lenzini L; Bisogni V; Seccia TM; Cesari M; Iacobone M; Rossi GP
    Surgery; 2018 Apr; 163(4):789-795. PubMed ID: 29198769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
    Witzgall H; Thayil G; Weber PC
    Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR; Berg G; Tuck ML; Martin VI; Chandler DW; Mayes DM
    J Clin Endocrinol Metab; 1982 Mar; 54(3):523-7. PubMed ID: 7035483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
    Demura R; Naruse M; Isawa M; Onoda N; Naruse K; Yamakado M; Demura H
    Endocrinol Jpn; 1992 Apr; 39(2):169-76. PubMed ID: 1396349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.